Adductor Canal Block (ACB) Only for Postoperative Pain

Medical University of South Carolina, Charleston, SC
Postoperative Pain+1 More ConditionsAdductor Canal Block (ACB) Only - Drug
Any Age
All Sexes
What conditions do you have?

Study Summary

This trial will compare the effects of two types of nerve blocks on post-operative pain for patients undergoing ACL reconstruction.

Eligible Conditions
  • Postoperative Pain
  • Anterior Cruciate Ligament Injury

Treatment Effectiveness

Phase-Based Effectiveness

3 of 3
Phase 4
This is further along than 93% of similar trials

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: up to two months after surgery

0-72 hours post op
Post-Op Day 0-2
total postoperative opioid consumption (total MME)
up to two months after surgery
Range of Motion (degrees)
Terminal knee extension (degrees)

Trial Safety

Phase-Based Safety

3 of 3
This is further along than 85% of similar trials

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
No Placebo Group
All patients enrolled in this trial will receive the new treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2 Treatment Groups

Adductor Canal Block (ACB) Only
1 of 2
1 of 2

Active Control

82 Total Participants · 2 Treatment Groups

Primary Treatment: Adductor Canal Block (ACB) Only · No Placebo Group · Phase 4

Adductor Canal Block (ACB) Only
ActiveComparator Group · 1 Intervention: Adductor Canal Block (ACB) Only · Intervention Types: Drug
ActiveComparator Group · 1 Intervention: Adductor Canal Block (ACB) + iPACK Block · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to two months after surgery

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
870 Previous Clinical Trials
5,368,298 Total Patients Enrolled
2 Trials studying Postoperative Pain
168 Patients Enrolled for Postoperative Pain
Carey Breabaker, MDPrincipal InvestigatorMedical University of South Carolina

Eligibility Criteria

Age Any Age · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Has the FDA authorized Adductor Canal Block (ACB) for clinical use?

"There is an abundance of clinical data supporting the safety of Adductor Canal Block (ACB), leading to a score of 3 on our scale. This treatment has already been approved for medical use, rendering it in Phase 4 trials." - Anonymous Online Contributor

Unverified Answer

What is the current patient intake for this clinical trial?

"Affirmative. documents demonstrate that this clinical trial is currently enrolling individuals, with a first posting date of July 27th 2022 and a most recent edit on August 10th 2022. The study necessitates 82 participants across 1 site." - Anonymous Online Contributor

Unverified Answer

Are there opportunities for new participants to join this experiment?

"As per the data hosted on, this medical trial is proceeding and actively looking for candidates to participate. The study was first published on July 27th 2022 with a recent update occurring in August 10th of that same year." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.